Clin2
NCT07721545Possibly a fitNot yet recruiting

Tablet for small deep brain stroke

Perforating Artery InfarctionPAI

Part of Brain & nervous system, Heart & circulation clinical trials.

This study tests a new tablet that dissolves under the tongue to help people who just had a small stroke in the deep parts of the brain. The tablet might help improve recovery by reducing damage from the stroke.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2/Phase 3
Enrollment
944 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You are between 18 and 80 years old.
  • You had a stroke within the last 72 hours (3 days).
  • Your stroke is a small, isolated type (not caused by a large artery blockage or heart clot).
  • Your MRI shows a small stroke in a deep part of the brain, like the basal ganglia or pons, and it's not too large.
  • You are generally independent before this stroke (able to do daily tasks without help).
  • You have no severe bleeding risk, recent heart attack, or major surgery in the last few months.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06674460Recruiting· Phase 3
Edaravone Dexborneol tablet for stroke recovery

This trial tests a new sublingual tablet (Edaravone Dexborneol) to help people recover after a small stroke caused by disease of the small blood vessels in the brain. It aims to see if the drug can improve thinking and daily function.

Beijing
NCT07371624Recruiting· Phase 1/Phase 2
Study of B2065 for recent ischemic stroke

This trial tests an investigational drug called B2065 for people who have had a recent ischemic stroke (a stroke caused by a blockage in a blood vessel in the brain). The goal is to see if it is safe and if it might help improve recovery when given within 36 hours of stroke symptoms starting.

Beijing
NCT07040085Not yet recruiting· Phase 3
Study of Y-6 tablets for acute large vessel stroke

This trial tests whether a new tablet (Y-6) given under the tongue can improve recovery after a severe stroke caused by a blocked large blood vessel in the brain. The study is for people who are already scheduled to have a procedure to remove the blockage.

NCT07668323Recruiting· Phase 3
Clot-dissolving medication for stroke caused by medium vessel blockage

This study tests whether giving clot-dissolving medication directly into the blocked brain artery (intra-arterial thrombolysis) improves recovery from acute stroke caused by a medium-sized vessel blockage. It aims to see if this treatment helps patients regain function better than standard care.

Nanjing, Jiangsu
NCT07299994Recruiting
Intravenous thrombolysis for specific brain strokes

This trial tests whether a clot-busting drug given through a vein can help people with certain types of deep brain strokes that happen in small arteries. It looks at patients who can be treated within 24 hours of symptoms starting.

Vienna, State of Vienna
NCT06715007Recruiting
Study on blood thinners and artery health for small vessel stroke

This study tests whether a combination of antiplatelet drugs and artery-stabilizing medication can improve recovery after a small stroke caused by damage to tiny blood vessels in the brain. It may help prevent further strokes and support healing.

Nanjing, Jiangsu

Hear when a new Perforating Artery Infarction trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.